|
NONINVASIVE VENTILATION FOR ACUTE
EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
|
In selected
patients with acute exacerbations of COAD associated with respiratory
acidosis, NIV can
reduce the need for intubation (NNT 2), length of hospital stay and in hospital
mortality (NNT 5)
Level of Evidence 1- |
Citation/s:
Noninvasive
Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
New England Journal of Medicine. 1995; 333(13):817-22
Lead author's name and fax:
Brochard L
Three-part Clinical Question:
1) Patients - exacerbations of COAD
2) Treatment - Non invasive
ventilation
3) Outcome - avoiding intubation,
reducing hospital stay and mortality
Search Terms: NIV, noninvasive ventliation, COAD, COPD, exacerbation
The Study:
Non-blinded concealed randomised controlled trial with intention-to-treat.
The Study Patients: Patients admitted to ITU with COAD and a respiratory
acidosis
Control group (N = 42; 42 analysed): Patients received standard care with
oxygen limites to 5 litres by nasal prongs, and medications including heparin ,
antibiotic agents, bronchodilators and correction of electrolytes.
Experimental group (N = 43; 43 analysed): Patients received the same
medication as above with the addition of non-invasive ventilation
The Evidence:
|
Outcome |
Time to Outcome |
CER |
EER |
RRR |
ARR |
NNT |
|
INTUBATION |
ITU |
0.738 |
0.256 |
65% |
0.482 |
2 |
|
95% Confidence Intervals: |
40% to 91% |
0.296 to 0.668 |
1 to 3 |
|
IN HOSPITAL MORTALITY |
IN HOSPITAL |
0.286 |
0.093 |
67% |
0.193 |
5 |
|
95% Confidence Intervals: |
11% to 100% |
0.031 to 0.355 |
3 to 32 |
|
COMPLICATIONS |
ITU |
0.476 |
0.163 |
66% |
0.313 |
3 |
|
95% Confidence Intervals: |
26% to 100% |
0.126 to 0.500 |
2 to 8 |
Comments:
A well conducted randomised control trial. However it was not blinded due to the
nature of the intervention and was thus open to bias. In addition I have
reservations about the equal treatment of the control and experimental group in
that the control group was limited to 5 litres of oxygen whereas the
experimental group was not. Hypoxia was a minor criteria for intubation
EBM questions:
1) Do the methods allow adequate testing of the hypothesis? - yes; a well
designed and conducted study
2) Do the statistical tests correctly test the results to allow differentiation
of statistically significant result? - the tests stated seem correct but are not
repeatable by me to confirm a significant result
3) Are conclusions valid in light of results? - Yes in light of p value for
intubation, hospital mortality and complications
4) Did results get omitted and why? - no; all results were present on an
intention to treat basis
5) Did they suggest areas of further research? -no
6) Did they make recommendations based on results and were they appropriate? -
no
7) Is this study relevant to my clinical practice? - yes as it suggests the
avoidance of intubation by NIV is possible in a group of patients with COAD and
this will have an effect on survival. However the amonut of difference may not
be as large in my patients as the local standard treatment would include more
oxygen
8) What level of evidence does this
study represent? – 1-
9) What grade of recommendation
can I make on this result alone? - B
10) Should I change my practice because of theses results? - Yes, I should
consider the use of NIV in patients presenting with acute exacerbations of COAD
with respiratory acidosis
11) Should I audit my current practice because of these results? - Yes, I need
to consider the range of conditions with physiological variables we are
currently using NIV for and their outcomes. I should also audit COAD patients
who are intubated to ensure the opportunity to have received NIV has not been
missed
Conclusions:
NIV should be used in patients in Scotland who present with exacerbations of
COAD with respiratory acidosis if there are no contraindications
Appraised by: Michael MacMillan
Mhmacmillan@aol.com ; 05 August 2004
Email: Mhmacmillan@aol.com
Kill or Update By: Aug 2007
Printer Friendly View
©2004
Scottish Intensive Care Society Evidence-Based Medicine Group
|